Meta-analysis of P-wave Dispersion Values in Healthy Individuals: the Influence of Clinical Characteristics

Overview

Journal Ann Noninvasive Electrocardiol

Specialty Cardiology & Vascular Diseases

Date 2012 Jan 27

PMID 22276626

Citations 9

Authors

Udi Nussinovitch

Affiliations

Soon will be listed here.

Abstract

Background: P-wave dispersion (Pd) is an appealing marker for predicting the risk of developing atrial fibrillation. At present, no definitive cutoff value has been determined as to the diagnosis of high-risk patients. Our aims were to evaluate P-wave parameters of healthy subjects published in the literature, determine normal range and weighted means of Pd and P-wave parameters, and investigate the influences of gender, age, and BMI on the weighted results.

Methods: A systematic search of studies published in PubMed was conducted. Only studies which included control groups of healthy individuals were included.

Results: Of the 657 studies initially identified, 80 were eligible for inclusion. The total number of participants was 6,827. The highest reported Pd values were 58.56 ± 16.24 ms; the lowest were 7 ± 2.7 ms. The weighted mean was 33.46 ± 9.65 ms; weighted median was 32.2 ms. Gender and age were not found to be associated with significant influences on P-wave parameter values. High-normal BMI was not found to be associated with increased P-wave parameter values.

Conclusions: Pd, Pmax, and Pmin span a wide range of values in healthy individuals. Seemingly, abnormal values were often reported in healthy adults. The high variability of P-wave parameters in healthy individuals, and overlapping of the results with those reported for patients with increased risk for atrial fibrillation, might suggest that this technique has limited sensitivity and specificity. The variability between studies may stem from methodological issues and, therefore, there is a definite need for methodological standardization of Pd measurements.

Citing Articles

The Effect of Glycemic Status on P Wave Dispersion.

Ragavan N, Thavalam R, Moorthy S Cureus. 2024; 16(4):e58233.

PMID: 38745813 PMC: 11092425. DOI: 10.7759/cureus.58233.

Utility of P-Wave Dispersion in the Prediction of Atrial Fibrillation.

Chavez-Gonzalez E, Donoiu I Curr Health Sci J. 2019; 43(1):5-11.

PMID: 30595848 PMC: 6286725. DOI: 10.12865/CHSJ.43.01.01.

Novel electrocardiographic indices of arrhythmogenesis and blood lead level.

Pourafkari L, Tajlil A, Nader N Ann Noninvasive Electrocardiol. 2016; 22(5).

PMID: 27535113 PMC: 6931708. DOI: 10.1111/anec.12395.

The Effect of Synthetic Cannabinoids on P-Wave Dispersion: An Observational Study.

Sunbul E, Sunbul M, Terzi A, Calli S, Koca E, Bilici R Med Princ Pract. 2016; 25(5):483-7.

PMID: 27287436 PMC: 5588554. DOI: 10.1159/000447516.

Longitudinal evaluation of P-wave dispersion and P-wave maximum in children after transcatheter device closure of secundum atrial septal defect.

Grignani R, Tolentino K, Rajgor D, Quek S Pediatr Cardiol. 2015; 36(5):1050-6.

PMID: 25628159 DOI: 10.1007/s00246-015-1119-3.

References

Uyarel H, Kasikcioglu H, Dayi S, Tartan Z, Karabulut A, Uzunlar B . Anxiety and P wave dispersion in a healthy young population. Cardiology. 2005; 104(3):162-8. DOI: 10.1159/000087874. View

Babai Bigi M, Aslani A, Shahrzad S . Clinical predictors of atrial fibrillation in Brugada syndrome. Europace. 2007; 9(10):947-50. DOI: 10.1093/europace/eum110. View

Tukek T, Yildiz P, Akkaya V, Karan M, Atilgan D, Yilmaz V . Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann Noninvasive Electrocardiol. 2002; 7(3):222-7. PMC: 7027775. DOI: 10.1111/j.1542-474x.2002.tb00167.x. View

Turhan H, Yetkin E, Atak R, Altinok T, Senen K, Ileri M . Increased p-wave duration and p-wave dispersion in patients with aortic stenosis. Ann Noninvasive Electrocardiol. 2003; 8(1):18-21. PMC: 6932054. DOI: 10.1046/j.1542-474x.2003.08104.x. View

Cetinarslan B, Akkoyun M, Canturk Z, Tarkun I, Kahranman G, Komsuoglu B . Duration of the P wave and P wave dispersion in subclinical hyperthyroidism. Endocr Pract. 2003; 9(3):200-3. DOI: 10.4158/EP.9.3.200. View

Cagirci G, Cay S, Karakurt O, Eryasar N, Acikel S, Dogan M . P-wave dispersion increases in prehypertension. Blood Press. 2009; 18(1-2):51-4. DOI: 10.1080/08037050902779441. View

Katircibasi M, Deniz F, Pamukcu B, Binici S, Atar I . Effects of short-term propylthiouracil treatment on p wave duration and p wave dispersion in patients with overt hypertyroidism. Exp Clin Endocrinol Diabetes. 2007; 115(6):376-9. DOI: 10.1055/s-2007-971066. View

Erbay A, Turhan H, Saatci Yasar A, Bicer A, Senen K, Sasmaz H . Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis. Int J Cardiol. 2005; 102(1):33-7. DOI: 10.1016/j.ijcard.2004.03.079. View

Kose S, Kilic A, Iyisoy A, Kursaklioglu H, Lenk M . P wave duration and P dispersion in healthy children. Turk J Pediatr. 2003; 45(2):133-5. View

10.

Russo V, Ammendola E, De Crescenzo I, Docimo L, Santangelo L, Calabro R . Severe obesity and P-wave dispersion: the effect of surgically induced weight loss. Obes Surg. 2007; 18(1):90-6. DOI: 10.1007/s11695-007-9340-7. View

11.

Acar G, Sayarlioglu M, Akcay A, Sokmen A, Sokmen G, Altun B . Assessment of atrial electromechanical coupling characteristics in patients with ankylosing spondylitis. Echocardiography. 2009; 26(5):549-57. DOI: 10.1111/j.1540-8175.2008.00838.x. View

12.

Koken R, Demir T, Sen T, Kundak A, Oztekin O, Alpay F . The relationship between P-wave dispersion and diastolic functions in diabetic children. Cardiol Young. 2010; 20(2):133-7. DOI: 10.1017/S104795110999031X. View

13.

Senen K, Turhan H, Erbay A, Basar N, Saatci Yasar A, Sahin O . P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail. 2004; 6(5):567-9. DOI: 10.1016/j.ejheart.2003.12.020. View

14.

Tamer A, Gunduz H, Ozyildirim S . The cardiac effects of a mobile phone positioned closest to the heart. Anadolu Kardiyol Derg. 2009; 9(5):380-4. View

15.

Ozmen N, Cebeci B, Kardesoglu E, Celik T, Dincturk M, Demiralp E . P wave dispersion is increased in pulmonary stenosis. Indian Pacing Electrophysiol J. 2006; 6(1):25-30. PMC: 1501095. View

16.

Duru M, Seyfeli E, Kuvandik G, Kaya H, Yalcin F . Effect of weight loss on P wave dispersion in obese subjects. Obesity (Silver Spring). 2006; 14(8):1378-82. DOI: 10.1038/oby.2006.156. View

17.

Emul M, Dalkiran M, Coskun O, Yavuz R, Tosun M, Duran A . P wave and QT changes among inpatients with schizophrenia after parenteral ziprasidone administration. Pharmacol Res. 2009; 60(5):369-72. DOI: 10.1016/j.phrs.2009.07.008. View

18.

Gunes Y, Tuncer M, Guntekin U, Akdag S, Ali Gumrukcuoglu H . The effects of trimetazidine on p-wave duration and dispersion in heart failure patients. Pacing Clin Electrophysiol. 2009; 32(2):239-44. DOI: 10.1111/j.1540-8159.2008.02208.x. View

19.

Yavuzkir M, Ozturk A, Dagli N, Koca S, Karaca I, Balin M . Effect of ongoing inflammation in rheumatoid arthritis on P-wave dispersion. J Int Med Res. 2007; 35(6):796-802. DOI: 10.1177/147323000703500608. View

20.

Dilaveris P, Gialafos E, Sideris S, Theopistou A, Andrikopoulos G, Kyriakidis M . Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998; 135(5 Pt 1):733-8. DOI: 10.1016/s0002-8703(98)70030-4. View